Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein–Barr virus reactivation-Reference-Cited by-同舟云学术

Establishment of a nasopharyngeal carcinoma cell line capable of undergoing lytic Epstein–Barr virus reactivation

Published:2018-05-16 Issue:8 Volume:98 Page:1093-1104
ISSN:0023-6837
Container-title:Laboratory Investigation
language:en
Short-container-title:Lab Invest

Author:

Yip Yim Ling,Lin Weitao,Deng Wen,Jia Lin,Lo Kwok Wai,Busson Pierre^ORCID,Vérillaud Benjamin,Liu Xuefeng^ORCID,Tsang Chi Man,Lung Maria Li,Tsao Sai Wah

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,Pathology and Forensic Medicine

Link

http://www.nature.com/articles/s41374-018-0034-7.pdf

Reference36 articles.

1. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004;5:423–8.

2. Chan SY, Choy KW, Tsao SW, et al. Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer. 2008;122:2169–71.

3. Strong MJ, Baddoo M, Nanbo A, et al. Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol. 2014;88:10696–704.

4. Cheung ST, Huang DP, Hui AB, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer. 1999;83:121–6.

5. Dangles-Marie V, Pocard M, Richon S, et al. Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. Cancer Res. 2007;67:398–407.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Differential Protein Study on Bronchoalveolar Lavage Fluid at Different Stages of Silicosis;Combinatorial Chemistry & High Throughput Screening;2024-10

2. Noninvasive Photothermal Therapy of Nasopharyngeal Cancer Guided by High Efficiency Optical-Absorption Nanomaterial Enhanced by NIR-II Photoacoustic Imaging;International Journal of Nanomedicine;2024-07

3. Color morphing surfaces with effective chemical shielding;Nature Communications;2024-05-03

4. Synthetic BZLF1-targeted transcriptional activator for efficient lytic induction therapy against EBV-associated epithelial cancers;Nature Communications;2024-05-03

5. Nasopharyngeal Carcinoma Cell Lines: Reliable Alternatives to Primary Nasopharyngeal Cells?;Cells;2024-03-22